Literature DB >> 32437684

CELLector: Genomics-Guided Selection of Cancer In Vitro Models.

Hanna Najgebauer1, Mi Yang2, Hayley E Francies3, Clare Pacini4, Euan A Stronach5, Mathew J Garnett4, Julio Saez-Rodriguez6, Francesco Iorio7.   

Abstract

Selecting appropriate cancer models is a key prerequisite for maximizing translational potential and clinical relevance of in vitro oncology studies. We developed CELLector: an R package and R Shiny application allowing researchers to select the most relevant cancer cell lines in a patient-genomic-guided fashion. CELLector leverages tumor genomics to identify recurrent subtypes with associated genomic signatures. It then evaluates these signatures in cancer cell lines to prioritize their selection. This enables users to choose appropriate in vitro models for inclusion or exclusion in retrospective analyses and future studies. Moreover, this allows bridging outcomes from cancer cell line screens to precisely defined sub-cohorts of primary tumors. Here, we demonstrate the usefulness and applicability of CELLector, showing how it can aid prioritization of in vitro models for future development and unveil patient-derived multivariate prognostic and therapeutic markers. CELLector is freely available at https://ot-cellector.shinyapps.io/CELLector_App/ (code at https://github.com/francescojm/CELLector and https://github.com/francescojm/CELLector_App).
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer models; cell lines; genomics; in silico prescriptions; in vitro study; molecular subtyping; new algorithm; pharmacogenomics

Mesh:

Year:  2020        PMID: 32437684     DOI: 10.1016/j.cels.2020.04.007

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  14 in total

Review 1.  Precision oncology in metastatic colorectal cancer - from biology to medicine.

Authors:  Federica Di Nicolantonio; Pietro Paolo Vitiello; Silvia Marsoni; Salvatore Siena; Josep Tabernero; Livio Trusolino; Rene Bernards; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2021-04-16       Impact factor: 66.675

2.  CNpare: matching DNA copy number profiles.

Authors:  Blas Chaves-Urbano; Barbara Hernando; Maria J Garcia; Geoff Macintyre
Journal:  Bioinformatics       Date:  2022-05-31       Impact factor: 6.931

Review 3.  Computational estimation of quality and clinical relevance of cancer cell lines.

Authors:  Lucia Trastulla; Javad Noorbakhsh; Francisca Vazquez; James McFarland; Francesco Iorio
Journal:  Mol Syst Biol       Date:  2022-07       Impact factor: 13.068

4.  A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles.

Authors:  Rileen Sinha; Augustin Luna; Nikolaus Schultz; Chris Sander
Journal:  Cell Rep Methods       Date:  2021-06-21

5.  Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology.

Authors:  Brendan Reardon; Nathanael D Moore; Nicholas S Moore; Eric Kofman; Saud H AlDubayan; Alexander T M Cheung; Jake Conway; Haitham Elmarakeby; Alma Imamovic; Sophia C Kamran; Tanya Keenan; Daniel Keliher; David J Konieczkowski; David Liu; Kent W Mouw; Jihye Park; Natalie I Vokes; Felix Dietlein; Eliezer M Van Allen
Journal:  Nat Cancer       Date:  2021-09-30

6.  Pharmacogenomic Cluster Analysis of Lung Cancer Cell Lines Provides Insights into Preclinical Model Selection in NSCLC.

Authors:  Yueyue Shen; Ying Xiang; Xiaolong Huang; Youhua Zhang; Zhenyu Yue
Journal:  Interdiscip Sci       Date:  2022-04-27       Impact factor: 3.492

7.  Bridging the gap between cancer cell line models and tumours using gene expression data.

Authors:  Javad Noorbakhsh; Francisca Vazquez; James M McFarland
Journal:  Br J Cancer       Date:  2021-03-29       Impact factor: 7.640

8.  Evaluating the transcriptional fidelity of cancer models.

Authors:  Da Peng; Rachel Gleyzer; Wen-Hsin Tai; Pavithra Kumar; Qin Bian; Bradley Isaacs; Edroaldo Lummertz da Rocha; Stephanie Cai; Kathleen DiNapoli; Franklin W Huang; Patrick Cahan
Journal:  Genome Med       Date:  2021-04-29       Impact factor: 11.117

9.  An integrated landscape of protein expression in human cancer.

Authors:  Andrew F Jarnuczak; Hanna Najgebauer; Mitra Barzine; Deepti J Kundu; Fatemeh Ghavidel; Yasset Perez-Riverol; Irene Papatheodorou; Alvis Brazma; Juan Antonio Vizcaíno
Journal:  Sci Data       Date:  2021-04-23       Impact factor: 6.444

10.  MFmap: A semi-supervised generative model matching cell lines to tumours and cancer subtypes.

Authors:  Xiaoxiao Zhang; Maik Kschischo
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.